Ligand-biased activation of extracellular signal-regulated kinase 1/2 leads to differences in opioid induced antinociception and tolerance

Erin N Bobeck; Susan L Ingram; Sam M Hermes; Sue A Aicher; Michael M Morgan

doi:10.1016/j.bbr.2015.10.032

Back

Ligand-biased activation of extracellular signal-regulated kinase 1/2 leads to differences in opioid induced antinociception and tolerance

Journal article

Open access

Peer reviewed

Ligand-biased activation of extracellular signal-regulated kinase 1/2 leads to differences in opioid induced antinociception and tolerance

Erin N Bobeck, Susan L Ingram, Sam M Hermes, Sue A Aicher and Michael M Morgan

Behavioural brain research, Vol.298(Pt B), pp.17-24

02/01/2016

DOI: https://doi.org/10.1016/j.bbr.2015.10.032

Handle:

https://hdl.handle.net/2376/116721

PMCID: PMC4779316

PMID: 26497105

Files and links (1)

url

https://doi.org/10.1016/j.bbr.2015.10.032View

Published (Version of record) Open

Abstract

Butadienes - pharmacology

Nitriles - pharmacology

Enkephalin, Ala-MePhe-Gly- - pharmacology

Mitogen-Activated Protein Kinase 1 - antagonists & inhibitors

Mitogen-Activated Protein Kinase 3 - antagonists & inhibitors

Enzyme Inhibitors - pharmacology

Nociceptive Pain - enzymology

Periaqueductal Gray - drug effects

Analgesics, Opioid - pharmacology

Drug Tolerance - physiology

Male

Fentanyl - pharmacology

Nociceptive Pain - drug therapy

Rats, Sprague-Dawley

Periaqueductal Gray - enzymology

Animals

Mitogen-Activated Protein Kinase 3 - metabolism

Mitogen-Activated Protein Kinase 1 - metabolism

Opioids produce antinociception by activation of G protein signaling linked to the mu-opioid receptor (MOPr). However, opioid binding to the MOPr also activates β-arrestin signaling. Opioids such as DAMGO and fentanyl differ in their relative efficacy for activation of these signaling cascades, but the behavioral consequences of this differential signaling are not known. The purpose of this study was to evaluate the behavioral significance of G protein and internalization dependent signaling within ventrolateral periaqueductal gray (vlPAG). Antinociception induced by microinjecting DAMGO into the vlPAG was attenuated by blocking Gαi/o protein signaling with administration of pertussis toxin (PTX), preventing internalization with administration of dynamin dominant-negative inhibitory peptide (dyn-DN) or direct inhibition of ERK1/2 with administration of the MEK inhibitor, U0126. In contrast, the antinociceptive effect of microinjecting fentanyl into the vlPAG was not altered by administration of PTX or U0126, and was enhanced by administration of dyn-DN. Microinjection of DAMGO, but not fentanyl, into the vlPAG induced phosphorylation of ERK1/2, which was blocked by inhibiting receptor internalization with administration of dyn-DN, but not by inhibition of Gαi/o proteins. ERK1/2 inhibition also prevented the development and expression of tolerance to repeated DAMGO microinjections, but had no effect on fentanyl tolerance. These data reveal that ERK1/2 activation following MOPr internalization contributes to the antinociceptive effect of some (e.g., DAMGO), but not all opioids (e.g., fentanyl) despite the known similarities for these agonists to induce β-arrestin recruitment and internalization.

Metrics

11 Record Views

Details

Title: Ligand-biased activation of extracellular signal-regulated kinase 1/2 leads to differences in opioid induced antinociception and tolerance
Creators: Erin N Bobeck - Washington State University, Department of Psychology, 14204 NE Salmon Creek Ave, Vancouver, WA 98686, United States. Electronic address: erin.bobeck@mssm.edu
Susan L Ingram - Oregon Health & Science University, Department of Neurological Surgery, 3181 SW Sam Jackson Park Road, Portland, OR 97239, United States
Sam M Hermes - Oregon Health & Science University, Department of Physiology and Pharmacology, 3181 SW Sam Jackson Park Road, Portland, OR 97239, United States
Sue A Aicher - Oregon Health & Science University, Department of Physiology and Pharmacology, 3181 SW Sam Jackson Park Road, Portland, OR 97239, United States
Michael M Morgan - Washington State University, Department of Psychology, 14204 NE Salmon Creek Ave, Vancouver, WA 98686, United States
Publication Details: Behavioural brain research, Vol.298(Pt B), pp.17-24
Academic Unit: Psychology, Department of
Publisher: Netherlands
Grant note: DA027625 / NIDA NIH HHS R01 DA015498 / NIDA NIH HHS R01 DA027625 / NIDA NIH HHS DA015498 / NIDA NIH HHS
Identifiers: 99900547760501842
Language: English
Resource Type: Journal article